Deletion of PTENP1 has been reported to downregulate PTEN expression in breast and colon cancer [64] and melanoma [65], and downregulation of PTENP1 through methylation of its promoter sequence in clear-cell renal cell carcinoma suppresses cancer progression [66]. This evidence concerns the gene PTENP1 and colonic neoplasm.